Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies (Q34430052)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies |
scientific article |
Statements
1 reference
Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies (English)
1 reference
Takahisa Furuta
1 reference
Naohito Shirai
1 reference
Mitsushige Sugimoto
1 reference
Akiko Nakamura
1 reference
Akira Hishida
1 reference
Takashi Ishizaki
1 reference
1 reference
Identifiers
1 reference